...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Editorial: Warfarin reversal: Schism between clinical practice and published guidelines
【24h】

Editorial: Warfarin reversal: Schism between clinical practice and published guidelines

机译:社论:华法林逆转:临床实践与已发布指南之间的分裂

获取原文
获取原文并翻译 | 示例

摘要

In the study, the reason behind vitamin K administration was split somewhat equally between bleeding, urgent procedure, and ST-INR. A higher portion of the bleeding group received IV vitamin K while a higher portion of the ST-INR group received oral; patients needing correction for an urgent procedure showed no difference in route administered. The preference for IV in bleeding patients is in line with guidelines, but almost one-third of bleeding patients received oral vitamin K despite needing emergent reversal. Additionally, patients presenting with gastrointestinal bleeding may not adequately absorb oral vitamin K, so these patients especially could benefit from IV administration. The number of red blood cell units transfused in bleeding patients on IV versus oral was not statistically different. The time between baseline ST-INR results and administration of vitamin K therapy (lag time) was surprisingly long at medians of 5.5 and 22 hours at the upper limit. The study also showed that the dosage of vitamin K used did not affect posttreatment INR. Posttreatment INR was only affected by pretreatment INR and total duration of vitamin K therapy before testing.
机译:在这项研究中,服用维生素K的原因在出血,急诊程序和ST-INR之间平均分配。出血组较高的人群接受静脉注射维生素K,而ST-INR组较高的人群口服。需要进行紧急手术纠正的患者在给药途径上无差异。出血患者对静脉输注的偏爱符合指南,但尽管需要紧急逆转,但仍有近三分之一的出血患者接受了口服维生素K。此外,胃肠道出血患者可能无法充分吸收口服维生素K,因此这些患者尤其可以从静脉给药中受益。静脉输液和口服输血的出血患者的红细胞单位数量没有统计学差异。从基线ST-INR结果到服用维生素K治疗之间的时间(滞后时间)惊人地长,中位数为5.5,上限为22小时。该研究还表明,所用维生素K的剂量不会影响治疗后的INR。治疗后INR仅受治疗前INR和测试前维生素K治疗的总时间影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号